176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
8.44%
Positive growth while AVGO shows revenue decline. John Neff would investigate competitive advantages.
8.06%
Cost increase while AVGO reduces costs. John Neff would investigate competitive disadvantage.
8.64%
Gross profit growth exceeding 1.5x AVGO's 1.32%. David Dodd would verify competitive advantages.
0.19%
Margin expansion below 50% of AVGO's 1.49%. Michael Burry would check for structural issues.
10.37%
R&D growth while AVGO reduces spending. John Neff would investigate strategic advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
75.47%
Other expenses growth while AVGO reduces costs. John Neff would investigate differences.
8.92%
Operating expenses growth while AVGO reduces costs. John Neff would investigate differences.
8.43%
Total costs growth while AVGO reduces costs. John Neff would investigate differences.
11.48%
Interest expense change of 11.48% while AVGO maintains costs. Bruce Berkowitz would investigate control.
8.09%
D&A growth while AVGO reduces D&A. John Neff would investigate differences.
-31.78%
EBITDA decline while AVGO shows 0.69% growth. Joel Greenblatt would examine position.
1.48%
EBITDA margin growth exceeding 1.5x AVGO's 0.76%. David Dodd would verify competitive advantages.
-37.10%
Operating income decline while AVGO shows 2.94% growth. Joel Greenblatt would examine position.
-42.00%
Operating margin decline while AVGO shows 3.11% growth. Joel Greenblatt would examine position.
40.00%
Other expenses growth 1.25-1.5x AVGO's 28.14%. Martin Whitman would scrutinize cost items.
-37.00%
Pre-tax income decline while AVGO shows 6.08% growth. Joel Greenblatt would examine position.
-41.90%
Pre-tax margin decline while AVGO shows 6.26% growth. Joel Greenblatt would examine position.
235.51%
Tax expense growth while AVGO reduces burden. John Neff would investigate differences.
-46.12%
Net income decline while AVGO shows 12.35% growth. Joel Greenblatt would examine position.
-50.31%
Net margin decline while AVGO shows 12.54% growth. Joel Greenblatt would examine position.
-45.83%
EPS decline while AVGO shows 11.11% growth. Joel Greenblatt would examine position.
-46.67%
Diluted EPS decline while AVGO shows 14.29% growth. Joel Greenblatt would examine position.
0.08%
Share count reduction exceeding 1.5x AVGO's 1.70%. David Dodd would verify capital allocation.
-0.31%
Diluted share reduction while AVGO shows 0.00% change. Joel Greenblatt would examine strategy.